اميره عصام زكى رمضان
أستاذ مساعد
Serum Levels of Intercellular Adhesion Molecule-1 and TNF- in Patients with COVID-19 and Its Relation to Disease Severit
• 2022
معلومات البحث
المؤلفون
Amira E. Ramadan1
, Marwa S. Azab1
, Abeer E. Abdelmaksoud2
, Etemad A. Mohammad3
,
Nashwa A. Amin3
, Amira H. Allam*
3
, Samah M. Eldsouky4
, Amany K. Shahat1
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: Coronavirus disease 2019 (COVID-19) is a major health concern and can be devastating, especially for
the elderly. It causes a systemic inflammatory response, involving dysregulation and misexpression of many
inflammatory cytokines.
Objectives: To assess the cytokine profile in COVID-19 patients and detect its relation with disease severity.
Patients and methods: This study included 50 COVID-19 patients confirmed by reverse transcription–polymerase
chain reaction (RT-PCR), of whom 20 with severe pneumonia, 20 with moderate and 10 with mild disease, and 50
healthy control. Quantitative ELISA tests were performed for tumour necrosis factor alfa (TNF-α) and intercellular
adhesion molecule1 (ICAM-1).
Results: Level of ICAM-1 is higher in cases of COVID-19 than healthy controls (median for cases = 420 ng/ml). Also
TNF-α level is higher in cases with a median of 165 both levels were higher in CORADS 6 and positively correlated
with CT findings.
Conclusion: Patients with severe COVID-19 might have a cytokine storm syndrome and increased expression of
endothelial cell adhesion molecules as ICAM-1, which is related to COVID-19 and disease severity and may contribute
to coagulation dysfunction. Levels of ICAM 1 were associated with more severe CT findings and longer hospital stay,
also ICAM 1 and TNF can be used as diagnostic measures as they have a higher sensitivity specificity and predictive
values.
the elderly. It causes a systemic inflammatory response, involving dysregulation and misexpression of many
inflammatory cytokines.
Objectives: To assess the cytokine profile in COVID-19 patients and detect its relation with disease severity.
Patients and methods: This study included 50 COVID-19 patients confirmed by reverse transcription–polymerase
chain reaction (RT-PCR), of whom 20 with severe pneumonia, 20 with moderate and 10 with mild disease, and 50
healthy control. Quantitative ELISA tests were performed for tumour necrosis factor alfa (TNF-α) and intercellular
adhesion molecule1 (ICAM-1).
Results: Level of ICAM-1 is higher in cases of COVID-19 than healthy controls (median for cases = 420 ng/ml). Also
TNF-α level is higher in cases with a median of 165 both levels were higher in CORADS 6 and positively correlated
with CT findings.
Conclusion: Patients with severe COVID-19 might have a cytokine storm syndrome and increased expression of
endothelial cell adhesion molecules as ICAM-1, which is related to COVID-19 and disease severity and may contribute
to coagulation dysfunction. Levels of ICAM 1 were associated with more severe CT findings and longer hospital stay,
also ICAM 1 and TNF can be used as diagnostic measures as they have a higher sensitivity specificity and predictive
values.
